Skip to main content
. 2020 Apr;26(4):10.18553/jmcp.2020.26.4.520. doi: 10.18553/jmcp.2020.26.4.520

TABLE 3.

Changes in Anticholinergic Medication Use

RCT Participants n = 46 Local External Control n = 146 National External Control n = 1,745
ADS change, mean (95% CI)a −0.33 (−0.72, 0.07)b −0.20 (−0.42, 0.02) −0.33 (−0.39, −0.26)
Decreased, n (%)
  ADS 16 (34.8) 40 (27.4) 508 (29.2)
  Number of anticholinergics 13 (28.3) 37 (25.3) 486 (27.9)
  Number of strong anticholinergics 4 (8.7) 14 (9.6) 171 (9.8)

aAdjusted for baseline number of medications and anticholinergic burden.

bNot statistically significantly different from local or national samples; P = 0.58 and 0.28, respectively.

ADS = Anticholinergic Drug Scale; CI = confidence interval; RCT = randomized controlled trial